LivingGLP1
Study S002537

Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

Registration

Registration
NCT01033500
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Status
WITHDRAWN
Enrollment
0
Start
2010-07
Primary completion
2012-12
Lead sponsor
University of Wisconsin, Madison
Conditions
Islets of Langerhans Transplantation; Diabetes Mellitus, Type 1; Kidney Transplantation
Interventions
DRUG:Belatacept
Results posted
FALSE

Registered primary outcomes

  • Achieve and consistently maintain insulin independence in simultaneous islet-kidney transplant recipients for one year. [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.